Comparative drug trials in symptomatic and asymptomatic non-dysenteric amoebic colitis.
D000562:Amebiasis / Q000188:drug therapy*; D000563:Amebicides / Q000009:adverse effects / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy*; D003365:Costs and Cost Analysis; D004748:Entamoeba histolytica; D006801:Humans; D008795:Metronidazole / Q000009:adverse effects / Q000627:therapeutic use*; D010618:Phenanthrolines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos
D000563:Amebicides; D010618:Phenanthrolines; D010919:Placebos; D008795:Metronidazole